Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6520.0000 -19.50 (-0.30%)
NSE Nov 12, 2025 15:31 PM
Volume: 476.3K
 

6520.00
-0.30%
ICICI Securities Limited
Divi’s Laboratories’ (Divi’s) Q2FY26 result was in line with our expectations on all fronts. Constant currency growth slowed down to ~10.8% vs. 15% QoQ and 18% in FY25.
ICICI Securities Limited increased Sell price target of Divi's Laboratories Ltd. to 5400.0 on 09 Nov, 2025.
More from Divi's Laboratories Ltd.
Recommended